CSIMarket
 


Grifols Sa  (GRFS)
Other Ticker:  
 
 

GRFS's Operating Income Growth by Quarter and Year

Grifols Sa's Operating Income results by quarter and year




GRFS Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December 0.00 - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -



GRFS Operating Income forth quarter 2020 Y/Y Growth Comment
Grifols Sa in the forth quarter recorded Operating Loss of $ 0.00 millions.

According to the results reported in the forth quarter, Grifols Sa achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Grifols Sa' s Operating Income no change of % ranks overall at the positon no. in the forth quarter.

Explain Operating Income growth


GRFS Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Grifols Sa's forth quarter 2020 Operating Income $ 0.00 millions GRFS's Income Statement
Grifols Sa's forth quarter 2019 Operating Income $ 0.00 millions Quarterly GRFS's Income Statement
New: More GRFS's historic Operating Income Growth >>


GRFS Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Grifols Sa's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GRFS's IV. Quarter Q/Q Operating Income Comment


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GRFS's IV. Quarter Q/Q Operating Income Comment


Grifols Sa's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Operating Income 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
In the Dec 31 2020 period, Grifols Sa's cumulative trailing twelve month Operating Income remained unchanged compare to the same period a year ago.

Grifols Sa achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
In the Dec 31 2020 period, Grifols Sa's cumulative trailing twelve month Operating Income remained unchanged compare to the same period a year ago.

Grifols Sa achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
GRFS's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for GRFS's Competitors
Operating Income Growth for Grifols Sa's Suppliers
Operating Income Growth for GRFS's Customers

You may also want to know
GRFS's Annual Growth Rates GRFS's Profitability Ratios GRFS's Asset Turnover Ratio GRFS's Dividend Growth
GRFS's Roe GRFS's Valuation Ratios GRFS's Financial Strength Ratios GRFS's Dividend Payout Ratio
GRFS's Roa GRFS's Inventory Turnover Ratio GRFS's Growth Rates GRFS's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2020
Check cap Ltd-0.97%$ -0.974 millions
Haemonetics Corporation-1.18%$ -1.178 millions
Prestige Consumer Healthcare Inc -3.88%$ -3.875 millions
Pra Health Sciences Inc -4.22%$ -4.219 millions
Fonar Corp-4.36%$ -4.361 millions
Amgen Inc -5.53%$ -5.530 millions
Henry Schein Inc -7.71%$ -7.708 millions
Utah Medical Products Inc-8.51%$ -8.506 millions
Orthofix Medical Inc -9.52%$ -9.524 millions
Icon Plc-9.67%$ -9.669 millions
Encompass Health Corporation-10.41%$ -10.413 millions
Align Technology inc -10.75%$ -10.746 millions
Conmed Corporation-11.40%$ -11.399 millions
Radnet Inc -12.06%$ -12.064 millions
Corcept Therapeutics Inc-12.86%$ -12.861 millions
National Research Corporation-14.84%$ -14.839 millions
Kamada Ltd-15.57%$ -15.568 millions
Diversicare Healthcare Services Inc -15.76%$ -15.763 millions
Taro Pharmaceutical Industries Ltd-16.77%$ -16.765 millions
Davita Inc -17.49%$ -17.492 millions
Stryker Corp-20.66%$ -20.657 millions
Infusystem Holdings Inc-21.05%$ -21.053 millions
Genesis Healthcare Inc -21.41%$ -21.413 millions
National Healthcare Corp-22.54%$ -22.537 millions
Baxter International Inc -23.40%$ -23.396 millions
Pacific Health Care Organization Inc-23.89%$ -23.893 millions
Teleflex Incorporated-25.09%$ -25.094 millions
Healthcare Services Group Inc -25.61%$ -25.611 millions
Collplant Biotechnologies Ltd-26.63%$ -26.628 millions
Zimmer Biomet Holdings Inc -28.53%$ -28.533 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MDH's Profile

Stock Price

MDH's Financials

Business Description

Fundamentals

Charts & Quotes

MDH's News

Suppliers

MDH's Competitors

Customers & Markets

Economic Indicators

MDH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071